Biotricity (OTCMKTS:BTCY) is a digital health and medical device company specializing in remote cardiac monitoring solutions designed to improve patient outcomes and streamline clinical workflows. The company is focused on developing and commercializing wearable devices and cloud-based platforms that enable continuous, real-time monitoring of heart health. Biotricity’s technologies are intended to support physicians and healthcare providers in the early detection and management of cardiac arrhythmias and other cardiovascular conditions outside of traditional clinical settings.
At the core of Biotricity’s product portfolio is the Bioflux family of cardiac monitors, which includes FDA-cleared ambulatory electrocardiogram (ECG) devices and associated mobile applications. The company’s wearable patches and connected sensors capture physiological data that is securely transmitted to a HIPAA-compliant, cloud-based analytics platform. This digital health platform offers automated analysis, reporting, and physician notification features, helping clinicians identify arrhythmias, track treatment progress and manage patient caseloads more effectively. Biotricity also provides remote patient monitoring services that leverage reimbursement pathways available under U.S. healthcare regulations for chronic care management.
Biotricity serves a diverse customer base that spans cardiology clinics, hospitals, diagnostic laboratories and telehealth providers across the United States and select international markets. By integrating its technology with electronic medical records systems and offering turnkey monitoring services, the company aims to reduce hospital readmissions, lower healthcare costs and expand access to cardiac care in both urban and rural settings. Its solutions have been utilized in both ambulatory and post-acute care environments, reflecting a commitment to comprehensive cardiac wellness across the continuum of care.
Founded with a vision to transform cardiac diagnostics through wearable technology, Biotricity has obtained multiple clearances from regulatory authorities and established strategic partnerships with healthcare organizations. The company is led by Chief Executive Officer Erez Ben-Dov, whose background in biomedical engineering and telehealth entrepreneurship has guided the development of Biotricity’s core products. Under executive leadership, the company continues to advance its research and development efforts, pursuing innovative devices and software enhancements to address evolving needs in digital health and remote patient management.
